/

Workspace

Research & Review

Writing & Publishing

Data & Analysis

Utilities

Account

User Settings

A

Ana M. Bajo

Universidad de Alcalá(ES)

Claim or correct this author profile

Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.

83

Papers

1.5K

Citations

24

h-index

48

i10-index

Ana M. Bajo is an academic researcher from Universidad de Alcalá. The author has contributed to research in topics: Neuropeptides and Animal Physiology & Peptidase Inhibition and Analysis & Growth Hormone and Insulin-like Growth Factors. The author has an h-index of 24, co-authored 71 publications.

ORCID: 0000-0002-4944-4222

Research Topics

Neuropeptides and Animal Physiology Peptidase Inhibition and Analysis Growth Hormone and Insulin-like Growth Factors Prostate Cancer Treatment and Research Metal complexes synthesis and properties

Papers by this author

works

Targeted doxorubicin-containing luteinizing hormone-releasing hormone analogue AN-152 inhibits the growth of doxorubicin-resistant MX-1 human breast cancers.

2003 · PubMed · 51 citations

Ana M. Bajo Andrew V. Schally Gábor Halmos Attila Nagy

RNA interference-directed silencing of VPAC1 receptor inhibits VIP effects on both EGFR and HER2 transactivation and VEGF secretion in human breast cancer cells

2011 · Molecular and Cellular Endocrinology · 29 citations

https://doi.org/10.1016/j.mce.2011.08.031

Ana Valdehíta Marı́a J. Carmena Ana M. Bajo Juan Carlos Prieto

Effective treatment of experimental U-87MG human glioblastoma in nude mice with a targeted cytotoxic bombesin analogue, AN-215

2002 · British Journal of Cancer · 25 citations

https://doi.org/10.1038/sj.bjc.6600235

Z Szereday Andrew V. Schally Attila Nagy Arthur Plonowski

Effective treatment of experimental ES-2 human ovarian cancers with a cytotoxic analog of luteinizing hormone-releasing hormone AN-207

2002 · Anti-Cancer Drugs · 22 citations

https://doi.org/10.1097/00001813-200210000-00007

José M. Arencibia Ana M. Bajo Andrew V. Schally Magdalena Krupa

Transactivation of HER2 by vasoactive intestinal peptide in experimental prostate cancer: Antagonistic action of an analog of growth-hormone-releasing hormone

2007 · International Journal of Oncology · 21 citations

https://doi.org/10.3892/ijo.31.5.1223

Ana M. Bajo Juan Carlos Prieto Manuel Sánchez‐Chapado József Varga

Growth hormone-releasing hormone antagonists abolish the transactivation of human epidermal growth factor receptors in advanced prostate cancer models

2014 · Investigational New Drugs · 18 citations

https://doi.org/10.1007/s10637-014-0131-4

Laura Muñoz‐Moreno M. Isabel Arenas Marı́a J. Carmena Andrew V. Schally

Research topics

topics

Neuropeptides and Animal Physiology

Peptidase Inhibition and Analysis

Growth Hormone and Insulin-like Growth Factors

Prostate Cancer Treatment and Research

Metal complexes synthesis and properties

Chat about Author

Papers

Chat

Click to start Chat